Weekly Trade Information-191

author: SNC | Good Fortune

2026-04-24

New EU Regulation: Natural Flavors and Plant Extracts to Prioritize Synthetic Additive Replacement

On April 21, the European Food Safety Authority (EFSA) issued a new official announcement. It stipulates that starting in 2027, natural flavors and plant extracts shall be prioritized to replace certain synthetic additives in foods and dietary supplements, focusing on three major categories: antioxidants, preservatives and colorants.

The new regulation encourages manufacturers to adopt natural ingredients such as rosemary extract and tea polyphenols, while tightening the maximum usage limits for synthetic additives.

This policy will accelerate the clean-label upgrading of the European supplement market and trigger a sharp surge in orders for relevant natural raw materials. Enterprises in Germany, Spain and other European countries have already accelerated production capacity expansion.

(Source: European Food Safety Authority, EFSA)

Clean Label & Targeted Delivery Become Dual Core Trends

On April 23rd, Spate released its 2026 dietary supplement report, indicating the industry is accelerating its shift toward clean label and precision nutrition.

On the food additive front, European and U.S. policies are vigorously phasing out synthetic additives. The FDA plans to eliminate eight petroleum-based synthetic colorants, triggering a sharp surge in domestic demand for natural alternatives such as rosemary extract and plant polysaccharides.

In the supplement sector, consumer purchasing logic has shifted from simple ingredient stacking to targeted, condition-specific solutions. Gut health and cellular anti-aging products register outstanding growth.

Meanwhile, targeted delivery technologies including liposomes and nanoemulsions have become core competitive advantages, driving the industry’s transition from the raw material era to the absorption-driven era.

(Source: Spate Industry Report, Foodaily)

GeneIII Jinsan Ergothioneine Supplement Releases Clinical Consensus, Leading the Anti-Aging Sector

On April 16, the team led by Professor Ma Liangkun from Peking Union Medical College Hospital, together with GeneIII Jinsan Biotechnology and People’s Daily Health Client, jointly released the Industry Consensus on Human Clinical Application of Ergothioneine and Women’s Health Management.

Formulated with 99.99% pharmaceutical-grade ergothioneine, this supplement is backed by 8 clinical studies filed with the National Health Commission. It focuses on application scenarios such as ovarian anti-aging and postpartum rehabilitation, with an absorption rate close to 100%.

Endorsed by the Peking Union Medical Foundation, it is the first evidence-based ergothioneine supplement certified in China.

(Source: Peking Union Medical Foundation)

Breakdown of 2026 Vitafoods Europe Innovation Award Ingredients: Innovative Creatine Remains Highly Popular

In April 2026, the finalists of the Vitafoods Europe Innovation Awards were announced, covering 25 enterprises. Shortlisted products focus on eight major health tracks including sports nutrition and weight management, ranging from innovative raw materials and finished nutritional products to sustainability initiatives. The official winners will be unveiled on May 5.

Current shortlisted ingredients and products reflect three major industry trends: the industry is focusing on delivery and absorption technologies, health functions are evolving toward multi-system synergies, and corporate competition has shifted to comprehensive capability systems. Meanwhile, ESG and sustainability have become essential prerequisites for business cooperation across the European market.

Company: Mingchyi BiotechnologyIngredient: CreHytine®Features: An innovative creatine ingredient designed to address poor creatine absorption. It adopts a dual-mechanism hydrogel encapsulation technology. Encapsulated with gum arabic and magnesium, it protects creatine monohydrate from degradation in gastric acid and greatly enhances solubility. This upgrades traditional creatine into a milder, higher-efficiency functional raw material.

(Source: Herbridge)

Vitamin K3 Prices Surge Rapidly with Robust Market Transactions

Driven by rising raw material costs, vitamin K3 prices have climbed sharply over the past two weeks, with export orders scheduled for shipment into the third quarter.

In the domestic market, the current quoted price of MSB stands at RMB 90/kg, while MNB is priced at no less than RMB 100/kg, presenting a firm trading sentiment.

(Source: Weigao Daily)

China Bans Direct Consumption of Digestive Enzymes, Strict Regulation Reshapes Maternal & Infant Supplement Market

On April 21, Chinese market regulatory authorities issued an official notice clarifying that digestive enzyme products are classified as food-industrial enzyme preparations, which are strictly prohibited from direct consumption as ordinary supplements. They shall not be blended into solid beverages, compressed tablets, candies or other finished products for direct consumer intake.

This regulatory action targets the irregular promotion of imported digestive enzymes exposed in the March 15 Consumer Rights Day investigation, and large-scale product recalls have been initiated across national distribution channels.
The China National Center for Food Safety Risk Assessment emphasized that enzyme preparations must fully comply with GB 2760 national standards and are restricted exclusively to food processing applications.

The tightened supervision will accelerate the market consolidation of maternal and infant conditioning products, compelling manufacturers to shift to compliant tracks such as medicinal and edible homologous ingredients.

(Source: State Administration for Market Regulation)

Weekly Trade Information-192

Weekly Trade Information-190